Erik PhD

Principal Scientist at Akero Therapeutics - South San Francisco, CA, US

Erik PhD's Contact Details
HQ
650-487-6488
Location
Company
Akero Therapeutics
Erik PhD's Company Details
Akero Therapeutics logo, Akero Therapeutics contact details

Akero Therapeutics

South San Francisco, CA, US • 20 - 49 Employees
BioTech/Drugs

Akero Therapeutics is a clinical-stage cardio-metabolic company developing transformational treatments for non-alcoholic steatohepatitis (NASH), a disease without any approved therapies. Akero's lead product candidate, efruxifermin (EFX), an engineered Fc-FGF21 fusion protein, is currently being evaluated in a Phase 2b clinical trial as a potential treatment for NASH. Akero is headquartered in South San Francisco.

N/A
Details about Akero Therapeutics
Frequently Asked Questions about Erik PhD
Erik PhD currently works for Akero Therapeutics.
Erik PhD's role at Akero Therapeutics is Principal Scientist.
Erik PhD's email address is ***@akerotx.com. To view Erik PhD's full email address, please signup to ConnectPlex.
Erik PhD works in the Biotechnology industry.
Erik PhD's colleagues at Akero Therapeutics are Andrea Canavero, William White, Arindam Bose, Mark Iwicki, Thomas Quinn, Timothy Rolph, Louben Dorval and others.
Erik PhD's phone number is 650-487-6488
See more information about Erik PhD